These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Preclinical toxicology protocols of the Laboratory of Toxicology. Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104 [No Abstract] [Full Text] [Related]
47. In vitro species comparisons and metabolite identification. Dow P Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.10. PubMed ID: 22294177 [TBL] [Abstract][Full Text] [Related]
48. Some pharmacological consequences of species variation in rates of metabolism. Brodie BB; Reid WD Fed Proc; 1967; 26(4):1062-70. PubMed ID: 6028770 [No Abstract] [Full Text] [Related]
49. Pharmacodynamic and toxicological studies of Kalanchoe integra stem. Varma RK; Garg BD; Ahmad A Mater Med Pol; 1986; 18(4):207-10. PubMed ID: 3613680 [No Abstract] [Full Text] [Related]
50. Species differences: the basis for and importance of comparative toxicology. Oehme FW Clin Toxicol; 1970 Mar; 3(1):5-10. PubMed ID: 5520391 [No Abstract] [Full Text] [Related]
51. SYNTHESIS AND MUSCLE RELAXANT PROPERTIES OF 3-AMINO-4-ARYLPYRAZOLES. ANDERSON EL; CASEY JE; GREENE LC; LAFFERTY JJ; REIFF HE J Med Chem; 1964 May; 7():259-68. PubMed ID: 14204957 [No Abstract] [Full Text] [Related]
52. The pharmacology of 2-(ethylamino)-2-(2-thienyl)-cyclohexanone-HCl (CI-634). Chen G; Ensor CR; Bohner B J Pharmacol Exp Ther; 1969 Jul; 168(1):171-9. PubMed ID: 4978323 [No Abstract] [Full Text] [Related]
53. 6-(5-NITRO-2-FURYL)-AS-TRIAZINE-3,5(2H,4H)-DIONE. A POTENTIAL URINARY TRACT ANTIBACTERIAL. HAYES K J Med Chem; 1964 Nov; 7():819-20. PubMed ID: 14262824 [No Abstract] [Full Text] [Related]
55. Evaluation of drug formulations using LD50 testing in mice. Sheth PR; Shah NH; Pool W J Pharm Sci; 1977 Nov; 66(11):1567-70. PubMed ID: 915733 [TBL] [Abstract][Full Text] [Related]
56. [Comparative and evolutionary pharmacology]. Mikhel'son MIa Usp Fiziol Nauk; 1977; 8(3):3-27. PubMed ID: 19894 [No Abstract] [Full Text] [Related]
57. A search to predict potential for drug-induced cardiovascular toxicity. Hamlin RL Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547 [TBL] [Abstract][Full Text] [Related]
58. Preclinical toxicologic evaluation of chromomycin A3 (NSC-58 514) in mice, dogs and monkeys. Fleischman RW; Schaeppi U; Heyman IA; Phelan RS; Rosenkrantz H; Ilievski V Toxicol Appl Pharmacol; 1974 Feb; 27(2):259-70. PubMed ID: 4212258 [No Abstract] [Full Text] [Related]
59. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I. SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901 [No Abstract] [Full Text] [Related]
60. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council. Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]